Press Releases

Bayshore Home Health acquires exclusive rights to use new wound treatment technology

Mississauga, Ont., December 10, 2008 – Bayshore Home Health announced today it has the exclusive rights to provide advanced technology to stimulate healing and manage pain through an agreement with Mississauga-based Lorenz NeuroVasc. Bayshore Home Health will be the first company in Canada to offer Frequency Rhythmic Electrical Modulation System (FREMS ™) outside of hospitals and other institutional health care settings.

Individuals suffering from a foot or leg ulcer, the impact of a surgical procedure or who require hospice palliative wound care will benefit from Bayshore Home Health’s new service. FREMS ™ treatment is used to decrease pain and healing time, increase tissue oxygenation and improve quality of life for wound care patients. The treatment involves the application of an electrical signal through small electrodes placed on the skin.

“Faster healing and reduced pain are the benefits of this new technology,” says Katherine Grant-Brown, clinical practice leader at Bayshore Home Health. “We will be providing FREMS ™ treatments through our community care clinics and home visits. It’s anticipated the treatments will become an important part of our skin health and wound care program.”

The new treatment will be incorporated into Bayshore Home Health’s best-practice approach to complex wound care cases. The company has a standardized approach to wound care assessment, treatment and evaluation that ensures its clients receive consistent, high quality care no matter where they live in the country.
“We are delighted to be working with Bayshore Home Health,” says Denis Carrier, CEO of Lorenz NeuroVasc Inc. “This new agreement means that patients in homes and clinics across Canada will benefit from FREMS ™ technology to reduce pain and accelerate the healing process.”

FREMS ™ treatments are available at Bayshore Home Health’s community care clinics located in 22 major centres across the country including Vancouver, Mississauga, Ottawa and Halifax.

About Bayshore Home Health

Bayshore Home Health has been enhancing the quality of life, dignity and independence of Canadians in their homes since 1966. Canadian owned and operated, it is the country’s largest provider of home and community health care services, with more than 40 home care offices, 20 community care clinics and 8,000 employees. Its core services are in-home nursing, personal care and home support – which can be purchased directly by individuals and also accessed through government care programs, personal and group insurance plans and workplace safety insurance.

Its caregivers deliver more than 5.2 million hours of home care annually to over 57,000 clients. The company also provides nurse/caregiver staffing services, health education programs and treatments in its community dialysis centres. Through its subsidiary, Bayshore Specialty Rx, it offers infusion pharmacy, infusion clinic and pharmaceutical support services to a variety of health care and pharmaceutical organizations. Bayshore Home Health has been a winner of Canada’s 50 Best Managed Companies award since 2006.

About Lorenz NeuroVasc

Lorenz NeuroVasc is a Canadian company operating as the exclusive supplier of FREMS ™ technology to the North American health care industry. FREMS ™ technology is the product of Lorenz Biotech S.p.A. of Modena, Italy, and is rapidly being adopted as a preferred treatment option in the European markets. Lorenz NeuroVasc is an important contributor to technology and scientific development, particularly in its sponsoring of various clinical trials. The company engages in direct sales, training, and service, through its own professional employee base. For more information visit www.lorenzneurovasc.ca.

– 30 –

For more information please contact:
Katherine Grant-Brown
Clinical Practice Leader
Bayshore Home Health
(705) 434-2246
kgbrown@bayshore.ca